logo

For the Inventor, By the Inventor

Vincent C O Njar

Glen Burnie, MD, United States of America

Vincent C O Njar

LinkedIn

This inventor holds 16 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: University System of Maryland, Tokai Pharmaceuticals, Inc., University of Washington. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincent C O Njar. Retrieved from https://idiyas.com/inventor/vincent-c-o-njar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 75.0

 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 55(Granted Patents)


Location History:

  • Baltimore, MD (US) (2001 - 2002)
  • Columbia, MD (US) (2007)
  • Lansdale, PA (US) (2015)
  • Glen Burnie, MD (US) (2011 - 2023)

Company Filing History:

goldMedal17 out of 2,025 
 
University System of Maryland
 patents
silverMedal2 out of 6 
 
Tokai Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 2,169 
 
University of Washington
 patents
4. 1 out of 3,693 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
5. 1 out of 536 
 
Thomas Jefferson University
 patents
where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12528776 - Composition and method for treating dermatological disorders using retinamides (2026-01-20),
2. 12391725 - Method for production of novel galeterone analogs and uses thereof (2025-08-19),
3. 11707468 - Methods of treating pancreatic cancer (2023-07-25),
4. 10675289 - Methods of treating pancreatic cancer (2020-06-09),
5. 10617685 - Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity (2020-04-14),
6. 10098896 - C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity (2018-10-16),
7. 9884067 - Androgen receptor down-regulating agents and uses thereof (2018-02-06),
8. 9808472 - Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies (2017-11-07),
9. 9694005 - Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity (2017-07-04),
10. 9439912 - Androgen receptor down-regulating agents and uses thereof (2016-09-13),
11. 9387216 - Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies (2016-07-12),
12. 9156792 - Retinamide and uses thereof (2015-10-13),
13. 7960435 - Anti-cancer agents and androgen inhibition activity compound (2011-06-14),
14. 7265143 - C-4 substituted retinoids (2007-09-04),
15. 6444683 - 17-azolyl steroids useful as androgen synthesis inhibitors (2002-09-03),

Title: The Innovative Journey of Vincent C O Njar

Introduction: Vincent C O Njar is a talented inventor based in Glen Burnie, MD (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Vincent C O Njar holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Vincent C O Njar has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Vincent C O Njar has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous projects.

Conclusion: Vincent C O Njar's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…